e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Tuberculosis in immunocompromised hosts
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tumor nekrozis faktor-alfa blockers and tuberculosis – Analysis of the 6 years
S. Börekçi, B. Duman, N. Mazican, K. Tascilar, B. Müsellim, G. Öngen, V. Hamuryudan (Istanbul, Turkey)
Source:
Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Session:
Tuberculosis in immunocompromised hosts
Session type:
Poster Discussion
Number:
1946
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Börekçi, B. Duman, N. Mazican, K. Tascilar, B. Müsellim, G. Öngen, V. Hamuryudan (Istanbul, Turkey). Tumor nekrozis faktor-alfa blockers and tuberculosis – Analysis of the 6 years. Eur Respir J 2011; 38: Suppl. 55, 1946
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
Asthma control test – Suitable for children from 4 to 11 years?
Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma
Year: 2010
Tracheobronchopathia osteochondroplastica – Analysis of 10 years period
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012
Tuberculosis – is there anything different over a decade?
Source: Annual Congress 2009 - Socio-economic impact of tuberculosis
Year: 2009
Interferon gamma release assays in screening for tuberculosis – Can we use them in patients with sarcoidosis?
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011
Kidney tuberculosis in last century and now – Is it the same disease?
Source: Annual Congress 2011 - Pulmonary and extrapulmonary tuberculosis
Year: 2011
Treatment of sarcoidosis – pentoxifylline
Source: Annual Congress 2009 - Pleural and parenchymal diseases
Year: 2009
Bacterial multidrug-resistance profile in a respiratory insufficiency unit – Analysis of 17 months
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012
Miliary tuberculosis during treatment with anti TNF alpha – A report of three cases
Source: Annual Congress 2012 - Tuberculosis: clinical findings I
Year: 2012
Post-menopausal mammary tuberculosis – Report of three cases
Source: Annual Congress 2011 - Management of tuberculosis
Year: 2011
Paraganglioma of the mediastinum – 18 years experience
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Regional reference centre for multi-drug resistant tuberculosis – 11 months of activity
Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis
Year: 2010
The
in-vitro
pharmacology of PF-4522971 – A novel inhaled Muscarinic M
3
Antagonist
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010
The results of drug resistance survey of MDR-strains on second line drugs obtains in national reference laboratory – " M.Nasta " Institute – Bucharest
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011
T spot TB reactivity – ²to treat or not to treat²
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Surgical treatment of pulmonary sequestration – 15-years experience
Source: Annual Congress 2010 - Congenital lesions and rare pathology
Year: 2010
Pulmonary tuberculosis – Still a challenging diagnosis
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011
Lung function in young adults – Which references should be taken?
Source: Annual Congress 2010 - Methods in respiratory epidemiology
Year: 2010
Clinical evaluation in 14 cases of diffuse alveolar hemorrhage – Relationship between initial findings and prognosis –
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010
Cryptogenic organising pneumonia – clarithromycin treatment – factors influencing treatment results and relapses
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009
Outcome of zinc & vit-A supplementation in the treatment
multidrug resistance
pulmonary tuberculosis patients
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept